Clinical Trial Update: PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the use of PET scanning in patients with lung or esophageal cancer who may undergo surgical removal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer, Lung Cancer | Phase 2, Phase 3 | Status: COMPLETED